AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
AbbVie Inc Kurs i Aktualny Cena
The current price of AbbVie Inc in the market is 847,18 zł, with a 24-hour trading volume of 5,21B zł. The asset's market cap is 1,49T zł, after moving -0.08% in the last day.
Tokenized AbbVie Inc is trading at 846,41 zł, with a tokenized market cap of 2,87M zł and a 24-hour trading volume of 371,08K zł. The tokenized asset has moved -0.33% in the past 24 hours.